Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) is still a consolidation treatment choice for relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL) patients and some aggressive B-cell NHL as frontline therapy. Due to the shortage of carmustine, we switc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Chen, Li, Yueyang, Liu, Su, Chen, Zehui, Zhang, Yizhuo, Yu, Yong, Yang, Hongliang, Zhao, Haifeng, Zhao, Zhigang, Yuan, Tian, Wang, Yafei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895978/
https://www.ncbi.nlm.nih.gov/pubmed/33608570
http://dx.doi.org/10.1038/s41598-021-81944-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895978/
https://www.ncbi.nlm.nih.gov/pubmed/33608570
http://dx.doi.org/10.1038/s41598-021-81944-8

Ejemplares similares